Cancer cell therapies could be approved next year: Juno, Kite Pharma

CHICAGO (Reuters) - A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells could begin reaching patients next year, according to companies presenting new data at the annual meeting of the American Society of Clinical Oncology.